# Phase 18 — Final Enterprise Release Verification: Final Synthesis

STATUS: **Verification complete.** This is the final phase of the
WhitePact Enterprise Neural master directive. This document is the
handoff artifact for the next authority in the review chain — the
directive's own closing instruction, restated here explicitly so it
is not lost in eighteen phases of detail:

> **DO NOT MERGE. The next authority after Claude is CODEX INDEPENDENT
> SECURITY REVIEW.**

`security/enterprise-neural-phase-0-1` (PR #50) remains **open and
unmerged**. Nothing in this phase changes that.

## 1. What this phase verified, not assumed

- **Full regression suite, run fresh at the end of this phase**: 3147
  passed, 1 skipped, 0 failed (`/tmp/full_run_phase18.log`) — not
  copied from an earlier phase's report.
- **PR #50's CI, re-checked via the GitHub API at the end of this
  phase**: 12/12 required checks passing (Lint · Type-check · Test on
  3.11 and 3.12, CodeQL ×2, dependency-review, gitleaks, dco-check,
  Helm chart lint, Accessibility, i18n, Build distribution).
- **CodeQL alert count, verified precisely**: `gh api
  .../code-scanning/alerts` filtered by `tool.name == "CodeQL"`
  returns **0 open alerts** — confirming Phase 1's original claim
  remains accurate. Filtering mattered: the same alerts endpoint also
  serves 58 open findings from a *different* tool, OpenSSF Scorecard
  (`scorecard.yml`), under rule IDs like `PinnedDependenciesID`/
  `MaintainedID`/`TokenPermissionsID` — an unfiltered read of that
  endpoint would have looked like 58 open CodeQL findings and been a
  false claim in either direction if reported carelessly. Named
  honestly: those 58 Scorecard findings are real, open, on `main`, and
  out of scope for this directive to close — a separate, pre-existing
  posture item, not hidden by imprecise wording here.

## 2. A real accuracy gap found and fixed this phase

`PROGRESS_LEDGER.md`'s "Commit" column said "pending (uncommitted at
ledger update time)" for every phase from 2 through 17 — true at the
instant each entry was drafted (the ledger update and the phase's own
commit land together, so the SHA doesn't exist yet mid-edit), never
backfilled afterward. Every one of those commits now exists, pushed,
with a real SHA. Backfilled in this phase — the same staleness class
Phases 12 (`THREAT_MODEL.md`) and 15 (`SECURITY_ASSURANCE_CASE.md`)
already found and fixed for other documents in this directive.

## 3. What this branch actually delivered (Phases 0-1, 2, 4-8, 10-17)

See `PROGRESS_LEDGER.md` for the authoritative, per-phase record
(status, commit, test result, security result, residual risk) — not
duplicated here. In summary, by category:

**Foundation** (Phases 0-2): repository audit against the master
directive's own laws; Secure SDLC verification (CodeQL, dependency
review, Gitleaks, DCO all green); a real cryptographic key-management
foundation (`governance/crypto/`) wired into field encryption and SAML
session signing, not yet activated in any running deployment.

**Neural/BCI track** (Phases 4-7, 16 — 100% net-new product surface,
explicitly gated on your go-ahead before starting): data
classification and fail-closed consent policy; a device trust/
capability contract with no fabricated device adapter; a typed neural
decision contract with no fabricated decoder; intent attestation with
the mutation-invalidates-authorization property implemented literally
and tested against the directive's own worked examples; a scientific
evidence contract closing a real, previously-unenforced gap
(`CapabilityState.VALIDATED` claims now require actual qualifying
evidence, not just a trusted device transport). Consistently, across
all five phases: no device, decoder, model, or study was ever
fabricated to make a phase look more complete than the platform's
actual, real capabilities — the master directive's own anti-fabrication
rule (§63) held for the entire track.

**Hardening track** (Phases 8, 10-15, 17 — audit-first throughout):
every one of these phases found the underlying architecture already
substantially built by prior initiatives (Heart, Production
Integration, Authority Everywhere, SPEC.md's own "Brain" pipeline) and
added regression-tested *evidence* that documented properties actually
hold, rather than rebuilding what already existed. Two real gaps were
found and closed with actual new logic, not just tests: Phase 12's
`platform_isolation_problems()` (startup visibility for disabled
DNS-rebinding protection) and Phase 16's `evaluate_capability_validation_claim()`
(the scientific-evidence enforcement gap above). Phase 17 closed
`SECURITY_ASSURANCE_CASE.md`'s own named "no fuzz-testing" gap for one
real security boundary (the SSRF guard), finding zero bugs across 700
generated adversarial inputs. Phase 15 found and fixed staleness in
the platform's own security-assurance documentation — both
understated real coverage (a mirror-image "no false claims" problem)
and one out-of-date version reference.

**Deferred, per your explicit direction, not silently dropped**:
Phase 3 (Zero-Trust Identity + Tenant Isolation) — tracked via
`docs/heart-production/` Phase 3+. Phase 9 (Heart Production Authority
Integration) — merged into the already-in-progress
`docs/heart-production/` initiative.

## 4. Aggregate residual risks — the honest final accounting

Collected from every phase's own report, not softened for this
summary:

- **Application-startup wiring for the Phase 2 crypto foundation is
  absent across all call sites** — the single largest residual risk
  spanning the whole cryptographic foundation.
- **No concrete `BCIDeviceAdapter`, decoder, or scientific evidence
  record exists** — deliberate, per the anti-fabrication discipline;
  real device/vendor decisions remain a separate, future go/no-go.
- **The self-hosted stdio MCP transport remains ungoverned** — named
  independently in Phases 8, 10, 11, and 12; architectural (no
  organizational identity exists on that transport to build a
  decision against), not an oversight.
- **No richer policy rule language (OPA/Rego)** — explicitly out of
  scope per SPEC.md §3.5's own stated future-iteration note.
- **No real KMS/HSM backend, no automated external evidence-anchoring
  publication pipeline, no application-layer MCP message signing, no
  SSE per-connection DoS protection** — each has a real, working seam
  or mitigating mechanism already built (Phase 2's `KeyProvider`
  Protocol; Phase 13's `evidence_bundle.py`), but the concrete,
  infrastructure-specific integration needs an explicit go-ahead
  naming a target this directive never received.
- **No independent penetration test, no SOC 2/ISO 27001 certification**
  — named plainly in `SECURITY_ASSURANCE_CASE.md` §8 since before this
  directive began, unchanged by it; real, external, cost-gated work.
- **58 open OpenSSF Scorecard findings on `main`** — discovered during
  this phase's own CodeQL-alert verification, not previously
  cataloged anywhere in this directive's eighteen phases. Genuinely
  new information, named here rather than silently noticed and
  dropped: mostly medium-severity `Pinned-Dependencies` findings, plus
  a handful of high-severity ones (`Maintained`, `Token-Permissions`
  ×2, `Code-Review`). Not investigated or triaged by this phase — that
  is real, separate work for whoever picks it up next, flagged here
  for the first time.
- **`ExecutionAuthorization` remains deliberately unsigned** —
  correct as long as it never crosses a process boundary; would need
  the same key-management infrastructure named above if a future
  executor lives in a separate process.

## 5. What has never happened, stated plainly

No commit on this branch has been merged into `main`. PR #50 remains
open. No independent review — Codex or otherwise — has occurred yet.
No claim anywhere in this directive's eighteen phases asserts
otherwise.
